Jean de Dieu Habimana

Jean de Dieu Habimana

Auto-generated profile, based on publicly available information

Jean de Dieu Habimana

Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2022 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
JHJean de Dieu Habimana
Jean de Dieu Habimana
RHRongqi Huang
Rongqi Huang
BMBertrand Muhoza
Bertrand Muhoza
YKYvan Ndayambaje Kalisa
Yvan Ndayambaje Kalisa
XHXiaobo Han
Xiaobo Han
ZLZhiyuan Li
Zhiyuan Li

9 May 2018 in Analytical Letters
Verified
Journal Article
Closed access
JHJean de Dieu Habimana
Jean de Dieu Habimana
JJJian Ji
Jian Ji
XSXiulan Sun
Xiulan Sun
This review considers the evolution of optical-based biosensors for bacterial pathogen detection as the causative agents for different diseases. Conventional identification and detection techniques are tedious, expensive and time-consuming, typically requiring sample pretreatment and hours to days to provide the results. For the successful monitoring of bacterial pathogen infection, fast, accurate, cost-effective and reliable techniques to simultaneously detect multiple bacterial pathogens and microbial metabolites are of the utmost importance in fields such as the food industry and healthcare. In addition, miniaturized, small amount of sample, easy to use with minimal accessories, and portable device should take advantage for rapid and point-of-care (POC) diagnosis. Optical transduction plays a substantial character in the development of such miniaturized and integrated biosensors as the alternatives to conventional analytical methods. In this review, we consider trends in point-of-care bacterial pathogen detection, different biorecognition elements, immobilization techniques, and optical based transduction methods applied for bacterial pathogen detection along with the respective advantages and drawbacks of each technique. Moreover, some examples of recently reported techniques for point-of-care analysis are also discussed. The analytical performance and characteristics of an ideal biosensor are discussed based on literature biosensor descriptions.

4 December 2021 in Foods
Verified
Journal Article
Open access
PDF file
Theoneste NiyigabaTheoneste Niyigaba
Theoneste Niyigaba
DLDiru Liu
Diru Liu
JHJean De Dieu Habimana
Jean De Dieu Habimana
Plant polysaccharides, as prebiotics, fat substitutes, stabilizers, thickeners, gelling agents, thickeners and emulsifiers, have been immensely studied for improving the texture, taste and stability of fermented foods. However, their biological activities in fermented foods are not yet properly addressed in the literature. This review summarizes the classification, chemical structure, extraction and purification methods of plant polysaccharides, investigates their functionalities in fermented foods, especially the biological activities and health benefits. This review may provide references for the development of innovative fermented foods containing plant polysaccharides that are beneficial to health.

10 December 2020 in Biosensors
Verified
Journal Article
Open access
PDF file
JWJinghua Wu
Jinghua Wu
OMOmar Mukama
Omar Mukama
WWWei Wu
Wei Wu
ZLZhiyuan Li
Zhiyuan Li
JHJean De Dieu Habimana
Jean De Dieu Habimana
LZLingwen Zeng
Lingwen Zeng
Cross-border pathogens such as the African swine fever virus (ASFV) still pose a socio-economic threat. Cheaper, faster, and accurate diagnostics are imperative for healthcare and food safety applications. Currently, the discovery of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) has paved the way for the diagnostics based on Cas13 and Cas12/14 that exhibit collateral cleavage of target and single-stranded DNA (ssDNA) reporter. The reporter is fluorescently labeled to report the presence of a target. These methods are powerful; however, fluorescence-based approaches require expensive apparatuses, complicate results readout, and exhibit high-fluorescence background. Here, we present a new CRISPR–Cas-based approach that combines polymerase chain reaction (PCR) amplification, Cas12a, and a probe-based lateral flow biosensor (LFB) for the simultaneous detection of seven types of ASFV. In the presence of ASFVs, the LFB responded to reporter trans-cleavage by naked eyes and achieved a sensitivity of 2.5 × 10−15 M within 2 h, and unambiguously identified ASFV from swine blood. This system uses less time for PCR pre-amplification and requires cheaper devices; thus, it can be applied to virus monitoring and food samples detection.

20 November 2022 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
JHJean de Dieu Habimana
Jean de Dieu Habimana
OMOmar Mukama
Omar Mukama
GCGuiquan Chen
Guiquan Chen
MCMengjun Chen
Mengjun Chen
OAObed Boadi Amissah
Obed Boadi Amissah
ZLZhiyuan Li
Zhiyuan Li

13 April 2024 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
LWLing Wang
Ling Wang
ZLZhaoduan Liang
Zhaoduan Liang
YGYunzhuo Guo
Yunzhuo Guo
JHJean de Dieu Habimana
Jean de Dieu Habimana
YRYuefei Ren
Yuefei Ren
YSYirong Sun
Yirong Sun
Antigen-specific T cell receptor-engineered T cell (TCR-T) based immunotherapy has proven to be an effective method to combat cancer. In recent years, cross-talk between the innate and adaptive immune systems may be requisite to optimize sustained antigen-specific immunity, and the stimulator of interferon genes (STING) is a promising therapeutic target for cancer immunotherapy. The level of expression or presentation of antigen in tumor cells affects the recognition and killing of tumor cells by TCR-T. This study aimed at investigating the potential of innate immune stimulation of T cells and engineered T cells to enhance immunotherapy for low-expression antigen cancer cells. We systematically investigated the function and mechanism of cross-talk between STING agonist diABZI and adaptive immune systems. We established NY-ESO-1 full knockout Mel526 cells for this research and found that diABZI activated STING media and TCR signaling pathways. In addition, the results of flow cytometry showed that antigens presentation from cancer cells induced by STING agonist diABZI also improved the affinity of TCR-T cells function against tumor cells in vitro and in vivo. Our findings revealed that diABZI enhanced the immunotherapy efficacy of TCR-T by activating STING media and TCR signaling pathways, improving interferon-γ expression, and increasing antigens presentation of tumor cells. This indicates that STING agonist could be used as a strategy to promote TCR-T cancer immunotherapy.